291 studies found for:    Open Studies | "Hepatitis C"
Show Display Options
Rank Status Study
21 Unknown  ADHEPTA Study: Adherence Questionnaire in Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV Infection
Intervention: Other: Adherence questionnaire
22 Recruiting Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: TT-034
23 Recruiting Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1)
Condition: Hepatitis C
Interventions: Drug: A: Peg-interferon alpha-2a & Ribavirin;   Drug: B: Peg-interferon alpha-2a & Ribavirin;   Drug: C: Peg-interferon alpha-2a & Ribavirin;   Drug: D: Peg-interferon alpha-2a & Ribavirin;   Drug: E: Peg-interferon alpha-2a & Ribavirin;   Drug: F: Peg-interferon alpha-2a & Ribavirin
24 Unknown  Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)
Conditions: Hepatitis C, Chronic;   Liver Diseases;   Interferon Deficiency
Intervention: Drug: interferon alpha 2b
25 Unknown  Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.
Condition: Chronic Hepatitis C
Intervention: Biological: Hydroxychloroquine (HCQ), Pegylated Interferon Alpha-2a (Peg-IFN alpha-2a) and Ribavirin
26 Recruiting An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C
Conditions: Hepatitis;   Hepatitis C
Interventions: Drug: Algeron;   Drug: Pegasys
27 Recruiting Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in Treatment-Naïve HCV Genotype 1-Infected Adults With Chronic Kidney Disease
Conditions: Chronic Hepatitis C;   Hepatitis C Virus;   Compensated Cirrhosis;   Severe Renal Impairment;   End-stage Renal Disease
Interventions: Drug: ombitasvir/ABT-450/ritonavir;   Drug: dasabuvir;   Drug: Ribavirin
28 Recruiting A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With and Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
Condition: Chronic Hepatitis C Virus Infection
Interventions: Drug: Ombitasvir/ABT-450/r;   Drug: Sofosbuvir;   Drug: Ribavirin (RBV)
29 Recruiting Effect of Camel Milk on Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon,  Ribavirin, camel milk;   Drug: Peginterferon,  Ribavirin
30 Unknown  Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated interferon alfa and ribavirin
31 Recruiting The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients
Condition: Hepatitis C
Intervention: Biological: Peginterferon lambda
32 Unknown  Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance
Conditions: Chronic Hepatitis c;   Insulin Resistance
Interventions: Drug: metformin;   Drug: pegylated-IFN;   Drug: ribavirin
33 Unknown  Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin Treatments
Condition: Chronic Hepatitis C
Intervention:
34 Recruiting A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With Genotype 1 HCV Who Failed a Prior DAA Containing Therapy
Conditions: Chronic Hepatitis C;   Hepatitis C Virus;   HCV
Interventions: Drug: ABT-493;   Drug: ABT-530;   Drug: Ribavirin
35 Unknown  Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?
Condition: Chronic Hepatitis C
Interventions: Drug: Peg + Vitamin D + Ribavirin;   Drug: Peg +  Ribavirin
36 Recruiting Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients
Condition: Chronic Hepatitis C Infection
Intervention:
37 Unknown  Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients
Condition: Chronic Hepatitis C
Intervention: Dietary Supplement: Vit D
38 Recruiting BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: BIP 48 (Peginterferon alfa 2b 48kDA);   Drug: Peginterferon alfa 2a 40kDA
39 Unknown  Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma
Conditions: Chronic Hepatitis C;   Neoplasms
Intervention: Drug: pegylated interferon alpha 2a and plus ribavirin
40 Recruiting Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl Alone or in Combination With Ribavirin in Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Chlorcyclizine HCL plus Ribavirin;   Drug: Chlorcyclizine HCL Only

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years